25.03.2010 • News

Hungary's Richter, Indian Astron Research to Develop Generics

Hungarian drug maker Richter Gedeon has formed a research partnership with India's Astron Research for the development of generic drugs, a Richter spokeswoman said on Wednesday. Richter will develop a range of commodity generics across multiple market segments with Astron, which it brought in to be able to focus on higher added-value processes, Zsuzsa Beke told Reuters on the phone.

"It has been our strategy for some time to focus on high added-value products," she said. The Hungarian drug maker will enjoy exclusive sales rights on any newly developed drugs in Russia, where it has mature marketing channels, Beke added.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.